In a new meta-regression analysis in T2D patients (60,079 patients, 30,693 with GLP-1 RAs) reductions of HbA1C were associated with the reduction of three-point MACE-cardiovascular death, myocardial infarction, or stroke [174]. Here, GLP1R is linked to type 2 diabetes mellitus.